Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
about
Toxicity of MRI and CT contrast agentsMultiwalled carbon nanotube hybrids as MRI contrast agentsLanthanide probes for bioresponsive imagingIn situ imaging of metals in cells and tissuesTheranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery.Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.Rigid Mn(II) chelate as efficient MRI contrast agent for vascular imaging.Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentStrategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging.Lanthanide(III) complexes of aminoethyl-DO3A as PARACEST contrast agents based on decoordination of the weakly bound amino group.Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.Nanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity.Design of a Gd-DOTA-phthalocyanine conjugate combining MRI contrast imaging and photosensitization properties as a potential molecular theranostic.A bis(pyridine N-oxide) analogue of DOTA: relaxometric properties of the Gd(III) complex and efficient sensitization of visible and NIR-emitting lanthanide(III) cations including Pr(III) and Ho(III).A water-soluble and water-coordinated Mn(II) complex: synthesis, characterization and phantom MRI image study.Ln(iii)-complexes of a DOTA analogue with an ethylenediamine pendant arm as pH-responsive PARACEST contrast agents.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.Sample Shuttling Relaxometry of Contrast Agents: NMRD Profiles above 1 T with a Single DeviceOptical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.A simple approach to a new T8-POSS based MRI contrast agent.Impact of biopolymer matrices on relaxometric properties of contrast agents.Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages.Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imagingEffect of lanthanide complex structure on cell viability and association.Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imagingDissociation kinetics of Mn2+ complexes of NOTA and DOTA.Activatable T₁ and T₂ magnetic resonance imaging contrast agentsStructure, stability and relaxivity of trinuclear triangular complexes.Advantages of macromolecular to nanosized chemical-exchange saturation transfer agents for MRI applications.Synthesis, complexation and NMR relaxation properties of Gd3+ complexes of Mes(DO3A)3.Integrin Targeted MR Imaging.Lanthanide complexes as imaging agents anchored on nano-sized particles of boehmite.Imaging biomarkers or biomarker imaging?Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.Mn2+ complexes of 1-oxa-4,7-diazacyclononane based ligands with acetic, phosphonic and phosphinic acid pendant arms: stability and relaxation studies.Dynamic chiral-at-metal stability of tetrakis(d/l-hfc)Ln(III) complexes capped with an alkali metal cation in solution.Analytical methods for characterizing magnetic resonance probes.Oxidation-responsive Eu(2+/3+)-liposomal contrast agent for dual-mode magnetic resonance imaging.
P2860
Q22306013-C563B56D-4B14-4D19-8788-8506456097B9Q26740054-5B1318C5-A641-43BA-9607-E404F50C0484Q27000361-044D927D-426C-4B70-BF7E-5067A0AF90BCQ28662002-3E057939-EA64-4F69-944E-9E4AAAEA2989Q30438087-42D16B11-3311-4EB0-90C3-C9243A057120Q30571105-E2E695D7-DCF2-4CF6-A13F-5FE9B5A60625Q30575244-9FDC93C8-75CF-4FBD-9C7D-D94722F3C641Q30576125-F3EA0B5C-1709-4A26-B5C6-802A2A8D3A33Q30660032-6EB71D1B-E999-468F-ABC4-AAD22B0561B1Q30667860-37AC4786-9F4A-49E3-9B53-E28975766DCDQ30807730-D55E5739-3EC8-43AA-81E0-433A1A872A22Q30834488-2322EAA8-6697-4651-88B3-D1890154D890Q30843294-81C9C514-F0C6-4A9D-B588-F508EFFD3771Q30853705-52499E39-222A-4C47-BFE0-7653500009A2Q30978230-0DE37E17-B4FB-4A09-90A8-1C4EBCE12BBAQ31038836-5F06C230-EFD4-4FBA-B0B3-962EFA34858CQ31048535-00E9A53F-7541-4F4A-9C95-4D5FFA8B677AQ31052821-8D217C0C-6E76-42CD-B717-745F0412E3C5Q31083784-B1E365E5-DD1B-4A83-82AE-F77EC155593DQ31135238-124E3A19-5740-417B-BFA3-11A0D1D96411Q31147094-C81AFF67-10FC-4290-B878-BE03FC098696Q33463644-83547266-C71A-48B9-94EB-A4C0B4B58D06Q33525666-8BE1A1BA-BF58-453A-8537-C8ADD6905356Q33617992-9FE1A342-12F7-469F-BE01-E352EEF44489Q33665120-D5429A17-CC8C-492D-8D34-15D6075D5B39Q33767273-BE67CAFA-4838-46BF-870D-53B0AED4530CQ33768662-BAF666D1-D1CE-4579-BF18-FD043243FFCBQ33805938-1FA150C0-788B-4018-B35E-F1FDA31E8C6BQ33823740-2CDC9D62-A805-4895-B121-CD8A8D385F05Q33843389-FB8F08ED-958A-494E-AFCA-36E760B75879Q33852464-709725FF-CB47-495A-AE0A-027E8D82AC44Q33858379-D0A931A4-B450-47A8-A1E9-93D002AC41EAQ33890945-8AC16214-A864-40D4-89B6-D341F1C9864BQ33902440-987F55DA-47C8-4515-B277-46DF6378C8E2Q33963108-8BC3C057-7127-4382-A6EF-7EF2BA2D4382Q33997304-9EA1F2F5-285A-4AAF-93F0-A6AC6B85B258Q34009907-F3CE0CB7-8406-4146-B2A8-CB56E0DF844FQ34248827-0EA9EA32-D91C-417B-B0FD-EFCBFB863F64Q34280357-AE3D1E94-52DD-419C-9F05-0FB3125D677FQ34429253-39A63688-12A2-47F8-A09B-083011527532
P2860
Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Gadolinium(III) complexes as M ...... d properties of the complexes.
@ast
Gadolinium(III) complexes as M ...... d properties of the complexes.
@en
type
label
Gadolinium(III) complexes as M ...... d properties of the complexes.
@ast
Gadolinium(III) complexes as M ...... d properties of the complexes.
@en
prefLabel
Gadolinium(III) complexes as M ...... d properties of the complexes.
@ast
Gadolinium(III) complexes as M ...... d properties of the complexes.
@en
P2093
P2860
P356
P1433
P1476
Gadolinium(III) complexes as M ...... d properties of the complexes.
@en
P2093
Ivan Lukes
Vojtech Kubícek
P2860
P304
P356
10.1039/B719704G
P407
P50
P577
2008-03-27T00:00:00Z